Clinical Trial Update: 16.0040 Ankylosing Spondylitis Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for ankylosing spondylitis sponsored by Amgen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Snippet

Sponsor: Amgen | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED